Remove FDA Remove Medicaid Remove Medicare Remove Prescription Drug Pricing
article thumbnail

Monthly Round-Up of What to Read on Pharma Law and Policy

Bill of Health

Food and Drug Administration (FDA) advisory committees, an analysis of the key patents covering drugs recently approved by the FDA, and an examination of high-risk cardiovascular devices approved by the FDA for use in children and adolescents. Improving the Use of FDA Advisory Committees. N Engl J Med.

article thumbnail

Health Provider News

Hall Render

Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’ Million CALIFORNIA California hospital dismisses CEO California physician pleads guilty to $2.5M million expansion ‘Very, very unusual.’ million expansion ‘Very, very unusual.’

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Health Provider News – February 18, 2022

Hall Render

13-year Medicare payment dispute will return to HHS, court rules. Meet new FDA chief Dr. Robert Califf: 5 things to know. Only 14% of Hospitals Met Price Transparency Rule Compliance. Colorado mental health professionals incensed after Medicaid forum that was intended to clear the air.

article thumbnail

The Gap Between the Trump Administration’s Promise of Reducing Rx Costs for Consumers and What People Really Want

Health Populi

This is what happened to pharma stock prices on Friday after President Trump and Secretary of Health and Human Services Alex Azar outlined their new policies focusing on prescription drug prices. ” These prescriptions for lower pharma costs contrast with what most U.S. The graph is the Nasdaq U.S.